• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RBM10,一种新的 p53 调节剂。

RBM10, a New Regulator of p53.

机构信息

College of Korean Medicine, Kyung Hee University, Seoul 02447, Korea.

Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA.

出版信息

Cells. 2020 Sep 16;9(9):2107. doi: 10.3390/cells9092107.

DOI:10.3390/cells9092107
PMID:32947864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7563659/
Abstract

The tumor suppressor p53 acts as a transcription factor that regulates the expression of a number of genes responsible for DNA repair, cell cycle arrest, metabolism, cell migration, angiogenesis, ferroptosis, senescence, and apoptosis. It is the most commonly silenced or mutated gene in cancer, as approximately 50% of all types of human cancers harbor TP53 mutations. Activation of p53 is detrimental to normal cells, thus it is tightly regulated via multiple mechanisms. One of the recently identified regulators of p53 is RNA-binding motif protein 10 (RBM10). RBM10 is an RNA-binding protein frequently deleted or mutated in cancer cells. Its loss of function results in various deformities, such as cleft palate and malformation of the heart, and diseases such as lung adenocarcinoma. In addition, RBM10 mutations are frequently observed in lung adenocarcinomas, colorectal carcinomas, and pancreatic ductal adenocarcinomas. RBM10 plays a regulatory role in alternative splicing. Several recent studies not only linked this splicing regulation of RBM10 to cancer development, but also bridged RBM10's anticancer function to the p53 pathway. This review will focus on the current progress in our understanding of RBM10 regulation of p53, and its role in p53-dependent cancer prevention.

摘要

抑癌基因 p53 作为转录因子,调节负责 DNA 修复、细胞周期停滞、代谢、细胞迁移、血管生成、铁死亡、衰老和细胞凋亡的多种基因的表达。它是癌症中最常被沉默或突变的基因,因为大约 50%的人类癌症都存在 TP53 突变。p53 的激活对正常细胞是有害的,因此它通过多种机制受到严格调控。最近发现的 p53 调节因子之一是 RNA 结合基序蛋白 10(RBM10)。RBM10 是一种在癌细胞中经常缺失或突变的 RNA 结合蛋白。其功能丧失会导致各种畸形,如腭裂和心脏畸形,以及肺癌等疾病。此外,RBM10 突变在肺腺癌、结直肠癌和胰腺导管腺癌中经常观察到。RBM10 在可变剪接中起调节作用。最近的几项研究不仅将 RBM10 的这种剪接调控与癌症的发生联系起来,还将 RBM10 的抗癌功能与 p53 途径联系起来。这篇综述将重点介绍我们对 RBM10 对 p53 调节的理解的最新进展,以及它在 p53 依赖性癌症预防中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b54/7563659/a3ab2f1bb856/cells-09-02107-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b54/7563659/303da8ee304d/cells-09-02107-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b54/7563659/b2f423a714da/cells-09-02107-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b54/7563659/a3ab2f1bb856/cells-09-02107-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b54/7563659/303da8ee304d/cells-09-02107-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b54/7563659/b2f423a714da/cells-09-02107-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b54/7563659/a3ab2f1bb856/cells-09-02107-g003.jpg

相似文献

1
RBM10, a New Regulator of p53.RBM10,一种新的 p53 调节剂。
Cells. 2020 Sep 16;9(9):2107. doi: 10.3390/cells9092107.
2
RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53.RNA 结合基序蛋白 10 通过激活 p53 诱导细胞凋亡并抑制增殖。
Oncogene. 2020 Jan;39(5):1031-1040. doi: 10.1038/s41388-019-1034-9. Epub 2019 Oct 7.
3
Functional role of RBM10 in lung adenocarcinoma proliferation.RBM10 在肺腺癌增殖中的功能作用。
Int J Oncol. 2019 Feb;54(2):467-478. doi: 10.3892/ijo.2018.4643. Epub 2018 Nov 22.
4
Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing.功能分析揭示,RBM10 突变通过调节剪接而导致肺腺癌发病。
Sci Rep. 2017 Jan 16;7:40488. doi: 10.1038/srep40488.
5
The role of RBM10 mutations in the development, treatment, and prognosis of lung adenocarcinoma.RBM10 突变在肺腺癌的发生、治疗和预后中的作用。
Cell Cycle. 2020 Nov;19(21):2918-2926. doi: 10.1080/15384101.2020.1829801. Epub 2020 Oct 16.
6
RBM10: Harmful or helpful-many factors to consider.RBM10:有害还是有益——需考虑诸多因素。
J Cell Biochem. 2018 May;119(5):3809-3818. doi: 10.1002/jcb.26644. Epub 2018 Jan 19.
7
RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1/AKT/CREB signalling pathway.RBM10 通过 RAP1/AKT/CREB 信号通路抑制肺腺癌细胞增殖。
J Cell Mol Med. 2019 Jun;23(6):3897-3904. doi: 10.1111/jcmm.14263. Epub 2019 Apr 6.
8
RNA binding motif protein 10 suppresses lung cancer progression by controlling alternative splicing of eukaryotic translation initiation factor 4H.RNA 结合基序蛋白 10 通过调控真核翻译起始因子 4H 的可变剪接抑制肺癌进展。
EBioMedicine. 2020 Nov;61:103067. doi: 10.1016/j.ebiom.2020.103067. Epub 2020 Oct 23.
9
RNA-binding motif protein 10 represses tumor progression through the Wnt/β- catenin pathway in lung adenocarcinoma.RNA 结合基序蛋白 10 通过 Wnt/β-连环蛋白通路抑制肺腺癌肿瘤进展。
Int J Biol Sci. 2022 Jan 1;18(1):124-139. doi: 10.7150/ijbs.63598. eCollection 2022.
10
Tumor suppressor properties of the splicing regulatory factor RBM10.剪接调节因子RBM10的肿瘤抑制特性
RNA Biol. 2016;13(4):466-72. doi: 10.1080/15476286.2016.1144004.

引用本文的文献

1
RBM10 suppresses colorectal cancer invasion by regulating LncRNA SNHG17 alternative splicing.RBM10通过调节LncRNA SNHG17的可变剪接抑制结直肠癌侵袭。
Sci Rep. 2025 Apr 14;15(1):12761. doi: 10.1038/s41598-025-97869-5.
2
TMB is associated with the prognosis of egfr-mutated non-small cell lung cancer in Xuanwei, China.肿瘤突变负荷(TMB)与中国宣威地区表皮生长因子受体(EGFR)突变的非小细胞肺癌的预后相关。
Biomark Med. 2024 Dec;18(24):1123-1133. doi: 10.1080/17520363.2024.2432306. Epub 2024 Dec 5.
3
Down regulation of RBM10 promotes proliferation and metastasis via miR-224-5p/RBM10/p53 feedback loop in lung adenocarcinoma.

本文引用的文献

1
LncRNA AB073614 promotes the proliferation and inhibits apoptosis of cervical cancer cells by repressing RBM5.长链非编码RNA AB073614通过抑制RBM5促进宫颈癌细胞的增殖并抑制其凋亡。
Eur Rev Med Pharmacol Sci. 2020 Jul;24(13):7201. doi: 10.26355/eurrev_202007_21851.
2
Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2.MID1IP1 和 c-Myc 的共定位通过调节核糖体蛋白 L5 和 L11 和 CNOT2 而在肝癌生长中起关键作用。
Cells. 2020 Apr 16;9(4):985. doi: 10.3390/cells9040985.
3
Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?
RBM10的下调通过miR-224-5p/RBM10/p53反馈环促进肺腺癌的增殖和转移。
Heliyon. 2024 Jul 22;10(15):e35001. doi: 10.1016/j.heliyon.2024.e35001. eCollection 2024 Aug 15.
4
Expression pattern, immune signature, and prognostic value of RBM10 in human cancers.RBM10在人类癌症中的表达模式、免疫特征及预后价值
Histol Histopathol. 2025 Apr;40(4):493-508. doi: 10.14670/HH-18-790. Epub 2024 Jul 4.
5
RNA binding proteins in cardiovascular development and disease.RNA 结合蛋白在心血管发育和疾病中的作用。
Curr Top Dev Biol. 2024;156:51-119. doi: 10.1016/bs.ctdb.2024.01.007. Epub 2024 Mar 15.
6
RNA-binding motif protein 10 inactivates c-Myc by partnering with ribosomal proteins uL18 and uL5.RNA 结合基序蛋白 10 通过与核糖体蛋白 uL18 和 uL5 结合来失活 c-Myc。
Proc Natl Acad Sci U S A. 2023 Dec 5;120(49):e2308292120. doi: 10.1073/pnas.2308292120. Epub 2023 Nov 30.
7
An RBM10 and NF-κB interacting host lncRNA promotes JEV replication and neuronal cell death.RBM10 和 NF-κB 相互作用的宿主长非编码 RNA 促进 JEV 复制和神经元细胞死亡。
J Virol. 2023 Dec 21;97(12):e0118323. doi: 10.1128/jvi.01183-23. Epub 2023 Nov 22.
8
Functional Role of RBP in Osteosarcoma: Regulatory Mechanism and Clinical Therapy.RBP 在骨肉瘤中的功能作用:调控机制与临床治疗。
Anal Cell Pathol (Amst). 2023 Jun 30;2023:9849719. doi: 10.1155/2023/9849719. eCollection 2023.
9
Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma.靶向去分化脂肪肉瘤中的MDM2-p53信号通路。
Front Oncol. 2022 Nov 10;12:1006959. doi: 10.3389/fonc.2022.1006959. eCollection 2022.
10
Lycorine upregulates the expression of RMB10, promotes apoptosis and inhibits the proliferation and migration of cervical cancer cells.石蒜碱上调 RMB10 的表达,促进宫颈癌细胞凋亡,并抑制其增殖和迁移。
Int J Mol Med. 2022 Dec;50(6). doi: 10.3892/ijmm.2022.5201. Epub 2022 Nov 11.
靶向USP7介导的MDM2/MDMX-p53通路去泛素化用于癌症治疗:我们做到了吗?
Front Cell Dev Biol. 2020 Apr 2;8:233. doi: 10.3389/fcell.2020.00233. eCollection 2020.
4
PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma.PI3K 抑制剂抑制头颈部鳞状细胞癌中 MYC 依赖性突变 p53 的功能获得。
Clin Cancer Res. 2020 Jun 15;26(12):2956-2971. doi: 10.1158/1078-0432.CCR-19-2485. Epub 2020 Jan 22.
5
miR-335 modulates Numb alternative splicing via targeting RBM10 in endometrial cancer.miR-335 通过靶向子宫内膜癌细胞中的 RBM10 调节 Numb 可变剪接。
Kaohsiung J Med Sci. 2020 Mar;36(3):171-177. doi: 10.1002/kjm2.12149. Epub 2020 Jan 2.
6
Significance of TP53 mutation in bladder cancer disease progression and drug selection.TP53突变在膀胱癌疾病进展和药物选择中的意义。
PeerJ. 2019 Dec 16;7:e8261. doi: 10.7717/peerj.8261. eCollection 2019.
7
RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53.RNA 结合基序蛋白 10 通过激活 p53 诱导细胞凋亡并抑制增殖。
Oncogene. 2020 Jan;39(5):1031-1040. doi: 10.1038/s41388-019-1034-9. Epub 2019 Oct 7.
8
Alternative splicing of VEGFA is regulated by RBM10 in endometrial cancer.VEGFA 的可变剪接受 RBM10 在子宫内膜癌中的调控。
Kaohsiung J Med Sci. 2020 Jan;36(1):13-19. doi: 10.1002/kjm2.12127. Epub 2019 Oct 6.
9
Legends of p53: untold four-decade stories.p53传奇:不为人知的四十年故事
J Mol Cell Biol. 2019 Jul 19;11(7):521-522. doi: 10.1093/jmcb/mjz079.
10
The antimalarial drug amodiaquine stabilizes p53 through ribosome biogenesis stress, independently of its autophagy-inhibitory activity.抗疟药物阿莫地喹通过核糖体生物合成应激使p53稳定,与其自噬抑制活性无关。
Cell Death Differ. 2020 Feb;27(2):773-789. doi: 10.1038/s41418-019-0387-5. Epub 2019 Jul 8.